CTS

CTS Corporation Announces Date for First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
星期二, 四月 16, 2024

LISLE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the first quarter 2024 at approximately 8:00 a.m. (ET) on Wednesday, May 1, 2024.

Key Points: 
  • LISLE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the first quarter 2024 at approximately 8:00 a.m. (ET) on Wednesday, May 1, 2024.
  • A conference call to discuss first quarter 2024 results with management is scheduled for Wednesday, May 1st, 2024 at 10:00 a.m. (ET).
  • The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location.
  • A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will be archived for one year.

Blue Biofuels Initiates Engineering and Design for Their CTS Commercial Plant Positioned to Produce Ethanol from Cellulosic Materials

Retrieved on: 
星期二, 四月 16, 2024

In a recent development, Blue Biofuels Inc. (“BIOF”) proudly announces the commencement of an FEL 1 & 2 engineering study for a 2.4-million-gallon cellulosic ethanol facility.

Key Points: 
  • In a recent development, Blue Biofuels Inc. (“BIOF”) proudly announces the commencement of an FEL 1 & 2 engineering study for a 2.4-million-gallon cellulosic ethanol facility.
  • This endeavor is grounded in the company's innovative Cellulose-to-Sugar (CTS) system, which has undergone and is undergoing continuous refinement and optimization for the efficient conversion of cellulosic biomass into ethanol.
  • Even at this initial volume, it demonstrates the viability of the CTS process in yielding positive margins for cellulosic ethanol production.
  • Blue Biofuels is now poised to scale up its engineering design for larger facilities, leveraging the inherent advantages of scale to enhance profitability.

AVI Systems and Technology Partners Team to Contribute More Than $110,000 to the AVIXA Foundation’s Brad Sousa Impact Fund

Retrieved on: 
星期三, 四月 24, 2024

AVI Systems , the largest global audiovisual and unified collaboration systems integrator, today announced that contributions and pledges to the Brad Sousa Impact Fund established by AVIXA earlier this year have exceeded $110,000.

Key Points: 
  • AVI Systems , the largest global audiovisual and unified collaboration systems integrator, today announced that contributions and pledges to the Brad Sousa Impact Fund established by AVIXA earlier this year have exceeded $110,000.
  • “We contacted dozens of our technology solution partners recently and have obtained a tremendous response to our request to contribute to the Brad Sousa Impact Fund,” said Jeff Stoebner, CEO at AVI Systems.
  • Professionally, Brad was instrumental in his role as Chief Technology Officer at AVI Systems and also served on the AVIXA Board of Directors and on the board of the AVIXA Foundation.
  • Following Sousa’s death, the Brad Sousa Impact Fund was established by AVIXA in January 2024.

Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Retrieved on: 
星期四, 四月 11, 2024

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion.

Key Points: 
  • Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion.
  • As a result, cell therapy manufacturers can use CTS OpTmizer One SFM to help optimize their workflows and get T cell therapies to patients faster.
  • View the full release here: https://www.businesswire.com/news/home/20240411707187/en/
    Thermo Fisher Scientific has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium, a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T cell expansion.
  • The CTS OpTmizer One SFM expands Thermo Fisher Scientific’s Gibco Cell Therapy Systems (CTS) portfolio of products.

Communication Technology Services (CTS) Expands Presence with New Texas Office

Retrieved on: 
星期四, 四月 25, 2024

MARLBOROUGH, Mass., April 25, 2024 /PRNewswire/ -- Communication Technology Services (CTS), an in-building and campus connectivity solution provider, is proud to announce the opening of its new office in Carrollton, Texas. This expansion marks an important milestone for the company as it continues to innovate and grow in key markets. The new office expands CTS's nationwide footprint to 16 locations in major metropolitan areas that support operations across the United States to meet the growing demand for enterprise wireless networks.

Key Points: 
  • MARLBOROUGH, Mass., April 25, 2024 /PRNewswire/ -- Communication Technology Services (CTS), an in-building and campus connectivity solution provider, is proud to announce the opening of its new office in Carrollton, Texas.
  • This expansion marks an important milestone for the company as it continues to innovate and grow in key markets.
  • The location will complement an existing office in the Houston suburb of Spring, TX providing complete coverage throughout the region.
  • "We're excited to establish an additional office in Texas," said Shane Rubin, Executive Vice President – National Operations.

CleanTech Strategies Selected by U.S. Department of Energy to Advance Innovations in Flow Batteries, with Close Industry Collaboration

Retrieved on: 
星期二, 四月 23, 2024

SEATTLE, April 23, 2024 /PRNewswire/ -- Clean technology expert firm CleanTech Strategies (CTS) has been selected by the U.S. Department of Energy (DOE)'s Office of Electricity (OE) as one of three selectees to receive a $5 million award each to advance energy storage innovations to help deliver clean, affordable electricity to Americans. The DOE OE awards are through the Storage Innovations 2030: Technology Liftoff funding opportunity announcement.

Key Points: 
  • SEATTLE, April 23, 2024 /PRNewswire/ -- Clean technology expert firm CleanTech Strategies (CTS) has been selected by the U.S. Department of Energy (DOE)'s Office of Electricity (OE) as one of three selectees to receive a $5 million award each to advance energy storage innovations to help deliver clean, affordable electricity to Americans.
  • CTS appreciates DOE OE's further support of flow battery innovations, building on its sustained efforts for two decades.
  • CTS very much appreciates DOE OE's further support of flow battery innovations under the Storage Innovations 2030 program, which builds on its sustained efforts for two decades."
  • FBIG was established in 2023 as part of BCI in collaboration with CTS, and has grown into an industry-leading platform for industry collaboration and advancement.

Converge to Host First Quarter Fiscal 2024 Conference Call

Retrieved on: 
星期四, 四月 18, 2024

TORONTO and GATINEAU, QC, April 18, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that it will hold a conference call to discuss its first quarter fiscal 2024 results on Thursday, May 9th, 2024 at 8:00am EST.

Key Points: 
  • TORONTO and GATINEAU, QC, April 18, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that it will hold a conference call to discuss its first quarter fiscal 2024 results on Thursday, May 9th, 2024 at 8:00am EST.
  • The call will be hosted by the Converge leadership team, followed by a question-and-answer period.
  • Converge will report its financial results in the morning prior to the call.
  • Participant Dial-in Details with Operator Assistance:

Converge to Host First Quarter Fiscal 2024 Conference Call

Retrieved on: 
星期四, 四月 18, 2024

TORONTO and GATINEAU, QC, April 18, 2024 /CNW/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that it will hold a conference call to discuss its first quarter fiscal 2024 results on Thursday, May 9th, 2024 at 8:00am EST.

Key Points: 
  • TORONTO and GATINEAU, QC, April 18, 2024 /CNW/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF) is pleased to announce that it will hold a conference call to discuss its first quarter fiscal 2024 results on Thursday, May 9th, 2024 at 8:00am EST.
  • The call will be hosted by the Converge leadership team, followed by a question-and-answer period.
  • Converge will report its financial results in the morning prior to the call.
  • Participant Dial-in Details with Operator Assistance:

Converge Technology Solutions Announces GenAI Focused Partnership with Forum Systems

Retrieved on: 
星期四, 四月 18, 2024

TORONTO and GATINEAU, QC, April 18, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) is pleased to announce it has entered into a strategic partnership with Forum Systems, a leader in LLM and API technologies , to leverage QuantumSim™, a Secure Multi-LLM Gateway.

Key Points: 
  • TORONTO and GATINEAU, QC, April 18, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) is pleased to announce it has entered into a strategic partnership with Forum Systems, a leader in LLM and API technologies , to leverage QuantumSim™, a Secure Multi-LLM Gateway.
  • As Arun Chandrasekaran stated in recent Gartner® research , "Generative AI (GenAI) has the potential to transform businesses across industries.
  • Converge and Forum's partnership combines cutting-edge GenAI capabilities together with IT expertise to augment Converge's advisory offerings.
  • "Converge is thrilled to be partnering with Forum Systems on this groundbreaking AI solution for our clients," stated Greg Berard, Converge Chief Executive Officer.

Converge Technology Solutions Named North America Winner of IBM Partner Plus Award in Digital Defense Category

Retrieved on: 
星期四, 四月 11, 2024

TORONTO and GATINEAU, QC, April 11, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) today announced it is the Geography Winner of the 2024 IBM Partner Plus Award in the Digital Defense category for North America.

Key Points: 
  • TORONTO and GATINEAU, QC, April 11, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) today announced it is the Geography Winner of the 2024 IBM Partner Plus Award in the Digital Defense category for North America.
  • The inaugural IBM Partner Plus Awards celebrate business partners in the IBM Ecosystem who advance businesses, reshape industries, and create positive impact through partnership.
  • As a winner in North America, Converge has also been named a finalist for the global awards which will be announced at IBM Partner Plus Day during Think 2024 on May 20, 2024.
  • For more information on the IBM Partner Plus Awards including a list of the geography winners across all six categories, visit https://www.ibm.com/partnerplus/awards-winners .